Gabelli Funds’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-144,700
Closed -$7.39K 1122
2024
Q3
$7.39K Hold
144,700
﹤0.01% 1071
2024
Q2
$14.8K Hold
144,700
﹤0.01% 1056
2024
Q1
$21.7K Hold
144,700
﹤0.01% 1050
2023
Q4
$12.6K Hold
144,700
﹤0.01% 1069
2023
Q3
$24.6K Hold
144,700
﹤0.01% 1075
2023
Q2
$20.3K Hold
144,700
﹤0.01% 1078
2023
Q1
$24.6K Hold
144,700
﹤0.01% 1091
2022
Q4
$25K Hold
144,700
﹤0.01% 1131
2022
Q3
$11K Hold
144,700
﹤0.01% 1249
2022
Q2
$17K Hold
144,700
﹤0.01% 1278
2022
Q1
$20K Buy
+144,700
New +$24.3K ﹤0.01% 1332

Other funds holding NVACR

Gabelli Funds's NVACR Position: Q4 2024 in Review

Gabelli Funds sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2024, closing a stake of 144,700 shares — an estimated $7.39K sold.

Gabelli Funds first reported a position in NVACR in Q1 2022 and held it in 11 quarters. The position peaked at $25K in Q4 2022. 5 funds tracked by Wall St. Rank hold NVACR as of Q4 2024.

  • Gabelli Funds reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2024 after selling out during the quarter.
  • Gabelli Funds sold 144,700 NorthView Acquisition Corporation Rights shares in Q4 2024, an estimated $7.39K.
  • Gabelli Funds first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 11 quarters.
  • Gabelli Funds's NorthView Acquisition Corporation Rights position peaked at $25K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2024.

Based on Gabelli Funds's 13F filing for Q4 2024, filed 13 Feb 2025.